A detailed history of Concurrent Investment Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 19,187 shares of EW stock, worth $1.35 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,187
Previous 18,551 3.43%
Holding current value
$1.35 Million
Previous $1.71 Billion 26.11%
% of portfolio
0.04%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$59.7 - $93.78 $37,969 - $59,644
636 Added 3.43%
19,187 $1.27 Billion
Q2 2024

Jul 30, 2024

SELL
$84.3 - $94.31 $10,621 - $11,883
-126 Reduced 0.67%
18,551 $1.71 Billion
Q1 2024

May 07, 2024

SELL
$72.54 - $95.56 $290,377 - $382,526
-4,003 Reduced 17.65%
18,677 $1.78 Billion
Q4 2023

Apr 15, 2024

BUY
$61.71 - $77.76 $1.4 Million - $1.76 Million
22,680 New
22,680 $1.73 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.